Yannick Le Bris Selected Research

Yannick Le Bris Research Topics

7	Neoplasms (Cancer) 02/2024 - 09/2018
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 01/2018
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 01/2020
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 10/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2023 - 01/2018
2	Leukemia 01/2022 - 01/2019
1	VEXAS syndrome 02/2024
1	Thrombosis (Thrombus) 01/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023
1	Acute Kidney Injury (Acute Renal Failure) 03/2022
1	Paraproteinemias (Monoclonal Gammopathy) 03/2022
1	Cadaver (Cadavers) 10/2021
1	Inflammation (Inflammations) 08/2020
1	Polycythemia Vera 08/2020
1	Multiple Myeloma 07/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	COVID-19 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Disease Progression 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Essential Thrombocythemia 01/2018
1	Primary Myelofibrosis (Myelosclerosis) 07/2017

2	Immunoglobulin A (IgA)IBA 03/2022 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 09/2018
2	CytokinesIBA 01/2021 - 08/2020
2	Clofarabine (Clolar)FDA Link 01/2019 - 09/2018
2	flt3 ligand protein (flt3 ligand)IBA 01/2019 - 01/2019
1	Interleukin-2 (IL2)IBA 01/2024
1	Zoledronic Acid (Zometa)FDA Link 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	CPX-351IBA 07/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2023
1	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2023
1	VaccinesIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	LeptinIBA 08/2020
1	Interleukin-33IBA 08/2020
1	sphingosyl beta-glucosideIBA 08/2020
1	AntigensIBA 08/2020
1	trametinibIBA 07/2020
1	dabrafenibIBA 07/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Busulfan (Busulfex)FDA Link 01/2020
1	purineIBA 01/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Janus Kinase InhibitorsIBA 07/2017

3	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2019
2	Therapeutics 11/2023 - 07/2020
2	Stem Cell Transplantation 01/2022 - 07/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2024
1	Kidney Transplantation 02/2024
1	Drug Therapy (Chemotherapy) 01/2022